Approval Probability
TA Base Rate
Adjusted LOA
ML Risk
Formulation C ODT · 1 trial · 1 indication
| Arm | Type | Description |
|---|---|---|
| Viagra 50 mg tablet, administered with water. | ACTIVE_COMPARATOR | - |
| Formulation B ODT tablet 50 mg, administered without water. | EXPERIMENTAL | - |
| Formulation C ODT tablet 50 mg, administered without water. | EXPERIMENTAL | - |
| Formulation D ODT tablet 50 mg, administered without water. | EXPERIMENTAL | - |
| Name | Type | Description |
|---|---|---|
| Viagra 50 mg tablet | DRUG | Commercial tablet, 50 mg, single dose administered with water |
| Formulation B ODT tablet 50 mg | DRUG | Oral disintegrating tablet (ODT), 50 mg, single dose administered without water |
| Formulation C ODT tablet 50 mg | DRUG | ODT, 50 mg, single dose administered without water |
| Formulation D ODT tablet 50 mg | DRUG | ODT, 50 mg, single dose, administered without water |
Inclusion Criteria: * Healthy subjects * Weight: BMI from 17.5 to 30.5 Exclusion Criteria: * Evidence or history of clinically significant hematological, renal, endocrine, pulmonary, gastrointestinal, cardiovascular, hepatic, psychiatric, neurologic, or allergic disease (including drug allergies,...